Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

miR-135a-5p affects adipogenic differentiation of human adipose-derived mesenchymal stem cellsby promoting the Hippo signaling pathway.

Gao S., Yang D., Huang W., Wang T., Li W.

Laboratory Study on Hip, published in Int J Clin Exp Pathol (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Int J Clin Exp Pathol (2018)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
31938230
PMCID
PMC6958094
Citations
9

Abstract (original English)

MicroRNAs (miRNAs) have been extensively studied and play a regulatory role during adipogenesis. Specifically, many miRNAs participate in regulation of mesenchymal stem cell (MSC) differentiation into adipogenic and osteogenic lineages. However, the regulatory mechanisms of miR-135a-5p in the Hippo signaling pathway during adipogenesis need to be explored. In this study, we observed that miR-135a-5p promotes adipogenesis of human adipose-derived MSCs (hADMSCs). miR-135a-5p was overexpressed in adipocytes compared to hADMSCs and further upregulation of miR-135a-5p promoted proliferation and adipogenesis of hADMSCs. In contrast, miR-135a-5p reduction inhibited these processes. Luciferase activity detection and Western blotting confirmed that overexpressed miR-135a-5p had the ability to upregulate the HIPPO signaling pathway. Subsequently, we observed that miR-135a-5p is targeted to key negative regulators in the HIPPO signaling pathway, including MOB kinase activator 1B (MOB1B) and large tumor suppressor 1 (LATS1). Moreover, suppression of LATS1 and MOB1B upregulated the activity of TEAD. In conclusion, we have verified that miR-135a-5p plays an active role in adipogenesis by targeting LATS1 and MOB1B expression, thereby enhancing the HIPPO signaling pathway.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research